Trial Profile
Special Drug Use Surveillance of Takecab Tablets for "Prevention of Recurrence of Gastric/Duodenal Ulcer in Patients Receiving Non-steroidal Anti-inflammatory Drugs:Long-term Use"
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 07 Jan 2022
Price :
$35
*
At a glance
- Drugs Vonoprazan (Primary)
- Indications Duodenal ulcer; Gastric ulcer
- Focus Adverse reactions
- Sponsors Takeda
- 20 May 2020 Status changed from active, no longer recruiting to completed.
- 20 May 2019 Status changed from recruiting to active, no longer recruiting.
- 11 Feb 2019 Planned End Date changed from 31 Aug 2019 to 30 Apr 2020.